Publications on EmboGold Microspheres and Embosphere Microspheres for treatment of Uterine Fibroids and Meningioma

Product Publications

Company Literature
	EmboGold Updated Brochure

	Embosphere Updated Brochure

	Patient Guide for Embolization

	EmboGold Microspheres Pre-filled Syringe IFU

	EmboGold Microspheres Preparation & Administration

	Embosphere Microspheres vs. PVA Demonstration

Press Releases
	BioSphere Medical's HepaSphere Highlighted at Two Scientific Meetings in Europe

	BioSphere's UFE Awareness Campaign Continues with NBC-TV "Today" Show Appearance by Beverly Johnson

	BioSphere Medical Receives Market Clearance to Sell Embosphere(R) Microspheres in the People's Republic of China

	Study Published in JVIR Concludes That Embosphere(R) Microspheres Should Be the Preferred Agent for Uterine Fibroid Embolization

	BioSphere Medical Receives CE Mark Approval for Transarterial Chemoembolization Using HepaSphere(TM) Microspheres

	BioSphere Medical to Present at CIRSE 2007 Conference

	Article Published in the Journal of Vascular and Interventional Radiology Supports Long-Term Efficacy and Durability of Embosphere Microspheres

	BioSphere Medical Highlights a Scheduled Presentation and Abstracts at the 2007 SIR 32nd Annual Scientific Meeting

	BioSphere Medical Announces That a Live-Case and Scientific Presentation Featuring BioSphere's QuadraSphere Microspheres

	BioSphere Medical's HepaSphere(TM) Microspheres to Be Featured at CIRSE 2006 Conference

	FDA Clears BioSphere Medical's Next Generation EmboCath(R) Plus Infusion Microcatheter

	Arterial Embolization Effective in Patients with Liver Cancer Recurrence

	BioSphere Medical to Participate in Phase II Liver Cancer Study at The Johns Hopkins University School of Medicine

	FDA Clears BioSphere Medical's Next Generation Sequitor(TM) Steerable Guidewire

	BioSphere Medical Announces Three-Year Study